EP Patent

EP2767272A1 — Solid pharmaceutical dosage form of dolutegravir

Assigned to Ratiopharm GmbH · Expires 2014-08-20 · 12y expired

What this patent protects

The present invention relates to a solid pharmaceutical dosage form comprising dolutegravir, a method of its preparation and its use in the treatment of an HIV infection.

USPTO Abstract

The present invention relates to a solid pharmaceutical dosage form comprising dolutegravir, a method of its preparation and its use in the treatment of an HIV infection.

Drugs covered by this patent

Patent Metadata

Patent number: EP2767272A1
Jurisdiction: EP
Classification: —
Expires: 2014-08-20
Drug substance claim: No
Drug product claim: No
Assignee: Ratiopharm GmbH
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.